Cases of ROS1-rearranged lung cancer: when to use crizotinib, entrectinib, lorlatinib, and beyond?
Precision Oncology Tumor Board
Exploiting homologous recombination repair alterations in metastatic castrate-resistant prostate cancer: a case report and literature review
Utilizing genomic profiling in a patient with a thoracic malignancy of uncertain primary: case report
Targeting EGFR mutations needs to be more precise with co-mutations
Amanda Podolski, Enrico Castellucci, Balazs Halmos
Karine Darbinyan, Changcheng Zhu, Scott Scheinin, Harish Seethamraju, Balazs Halmos
Xuan Ge, Sara Tariq, Haiying Cheng, Balazs Halmos
Balazs Halmos, MD
The series “Precision Oncology Tumor Board” was commissioned by the editorial office, Precision Cancer Medicine without any sponsorship or funding. Balazs Halmos is serving as the unpaid Guest Editor for the series.